Loading...
Derniers dépôts
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
Nombre de documents
790
Nombre de notices
1 381
widget_cloud
Rare diseases
Neuromuscular disease
Actin
Fibrosis
RNA biology
Biomarkers
Amyotrophic lateral sclerosis
Myotonic Dystrophy
Treatment
Transgenic mouse model
Animals
Satellite cells
Muscle
RNA interference
Exercise
FSHD
Antisense oligonucleotides
Brain
Autoimmunity
Alternative splicing
Muscle regeneration
Errance diagnostique
Genotype phenotype correlation
Myopathies
Therapy
Trinucleotide repeat expansion
Biomarker
COVID-19
Transcriptomics
Heart failure
DMD
Neuromuscular diseases
Autoimmune diseases
Lamin A/C
Thérapie génique
Dilated cardiomyopathy
Laminopathies
CTG repeat contractions
Autoantibodies
Gene therapy
Dystrophin
Aging
Outcome measures
Heart
Cytoskeleton
Autophagy
Duchenne muscular dystrophy
ALS
MBNL
Becker muscular dystrophy
Regeneration
LMNA
Thymus
Myopathy
Lamin A/C LMNA gene
Clinical trials
LMNA gene
Laminopathie
Nuclear envelope
Motoneuron
Neuromuscular junction
Myotonic dystrophy
Rare neuromuscular diseases
OPMD
Humans
Myogenesis
Skeletal muscle
Myotonic dystrophy type 1
CMS
Dermatomyositis
Congenital myopathy
Cytokines
Muscular dystrophy
Aged
Fabry disease
Myasthenia gravis
CRISPRi
Mouse model
Inflammation
Satellite cell
PABPN1
Cell therapy
Cancer
Centronuclear myopathy
Glutamate
Long read sequencing
Male
Laminopathy
AAV
Myasthenia Gravis MG
Myoblasts
Dynamin 2
Oxidative stress
Mechanotransduction
Congenital muscular dystrophy
Myotonic Dystrophy type 1
Cardiomyopathy
Astrocyte
Myositis
Calcium